SlideShare a Scribd company logo
Shock
Dr.Indubala Maurya MD,DNB
Assistant Professor
Dept of Aanesthesia & Critical Care
MGMCRI
Introduction
 Shock can be defined as a state of inadequate
or inappropriate tissue perfusion resulting in
abnormal cellular metabolism.
 Shock is associated with anaerobic metabolism,
oxygen debt and tissue acidosis.
 Combination of hemodynamic parameters:
 MAP< 60
 SBP<90
 Clinical feature
 Abnormal lab value ( lactate > 4 mmol/L)
Types of shock
 Hypovolemic shock
 Distributive Shock
 Cardiogenic Shock
Hypovolemic shock
 Hypovolemic shock is related to decreased intravascular
volume, secondary to loss of:
 Blood (e.g. trauma)---- > Hemorrhagic shock
 Plasma (e.g. burns)
 Water and electrolytes (e.g. vomiting, diarrhoea).
Hypovolemic shock
 Clinical feature :
Hypovolemic shock
Management :
 Establish vascular access ; large bore cannula , Send
sample for Hb
 Start fluid resuscitation depending on clinical
presentation -----with crystalloid/Blood product
 Hb > 9gm% ----> continue Fluid therapy
 Hb < 9gm% --- > PRBC, correct coagulation abnormality
 Search for source of bleeding : compression of visible
vascular injury, exposure and control of internal bleeding,
embolisation ,banding
Measure CVP and MAP
 CVP < 8 --------> continue Fluid therapy
 CVP > 8 and MAP < 60 -----> Administer Vasopressor ( NE,DA)
 CVP > 8 and MAP > 60 ------> Resuscitation complete
 Others
 Airway control
 Plt/FFP
 Activated factor VII
 Calcium/magnesium supplement
 Rewarming
 Antibiotics
 look for other cause of shock
Distributive shock
e.g.
 Septic shock
 Anaphylactic shock
Septic shock
Surviving sepsis campaign 2012
Sepsis is defined as the presence of infection together with systemic
manifestations of infection.
Severe sepsis is defined as sepsis plus sepsis-induced organ
dysfunction or tissue hypo perfusion.
Sepsis-induced hypotension is defined as a systolic blood pressure
(SBP) < 90 mm Hg or mean arterial pressure (MAP) < 70 mm Hg or a SBP
decrease > 40 mm Hg or less than two standard deviations below normal
for age in the absence of other causes of hypotension
Septic shock
 Clinical feature
SBP< 90
MAP < 70
Feature of severe sepsis :
 Fever Hypothermia ,tachy,Tachypnea,Altered mental
status, Leukocytosis ,Leukopenia.
 With one or more organ involvement ( lung ,liver ,kidney )
Septic shock
Management
Goals during the first 6 hrs of resuscitation:
a) Central venous pressure 8–12 mm Hg
b) Mean arterial pressure (MAP) ≥ 65 mm Hg
c) Urine output ≥ 0.5 mL/kg/hr
d) Central venous (superior vena cava) or mixed venous
oxygen saturation 70% or 65%, respectively
 CVP < 8  continue fluid resuscitation
 CVP > 8
MAP < 65  add vasopressure
MAP > 65
 ScvO2 < 70 %
 Add dobutamine
 Transfuse if Hb < 7
 ScvO2 > 70 %  achieved all goals
•Fluid Therapy of Severe Sepsis:
• Crystalloids as the initial fluid of choice in the resuscitation
•Vasopressors
• Norepinephrine as the first choice vasopressor
•Inotropic Therapy
• Dobutamine infusion
• myocardial dysfunction as suggested by elevated cardiac
filling pressures and low cardiac output.
• ongoing signs of hypoperfusion, despite achieving adequate
intravascular volume and adequate MAP
•Blood Product Administration
• Red blood cell transfusion if Hb <7.0 g/dL
• Platelets prophylactically when counts are <10,000/mm3 in the
absence of apparent bleeding
Diagnosis :
• Cultures as clinically appropriate before antimicrobial therapy
• imaging
•Antimicrobial Therapy
• Administration of effective broad spectrum intravenous
antimicrobials within the first hour of recognition of septic shock.
• Not more than 5 days, De-escalate antibiotic therapy.
• Duration of therapy typically 7–10 days
•Source Control
• eg: abscess drainage
•Mechanical Ventilation of Sepsis-Induced ARDS
Anaphylactic shock
 Anaphylaxis :
 life threating clinical manifestation
 IgE mediated hypersensitivity
 Mast cell and basophil degranulation
 Anphylactoid rxn:
 Not IgE mediated
Anaphylactic shock
 Causes
 Anaphylaxis :
 Food( Nuts,egg etc)
 Antibiotics,vaccines blood n blood products,latex
 Anaphylactoid rxn
 NSAID
 Opiates
 Gamma globulin
 antisera
Anaphylactic shock
 Clinical manifestations :
 Eyes: conjuctival erthyrema, periorbital odema
 Skin: pruritus flushing urticaria angioedema
 CVS: hypotension, Tachy (Brady if severe), cardiac
arrest
 Resp: Dyspnea,wheezing,pulmonary odema
 GIT : Nausea/vomiting,Diarrohea, Abdo pain
Anaphylactic shock
 Suspected impending respiratory collapse ---->
intubate
 IM epinephrine 0.3-0.5 mg to ant/ lat thigh
 For severe symptoms poor response
 Iv bolus epinephrine 0.1-0.2 mg
 If hypotensive start fliud therapy
 if no response to above
 start iv epi infusion
 Aggressive fluid therapy
 Pt on beta blocker ----> Glucagon
 Treat all patients with Histamine 1,2 blocker
Diphenhydramine (H1)
Ranitidine (H2)
Cardiogenic shock
 Cardiogenic shock is related to ‘pump’
failure from many possible causes
 myocardial infarct ( common)
 valve dysfunction
 papillae rupture
 arrhythmias
 tamponade
 pulmonary embolus
Cardiogenic shock
 Clinical feature
SBP< 90
Sign of low cardiac output ( oliguria,poor
mental status , pulmonary odema )
 Adequate intravascular volume ( PAOP > 15
mmhg)
Cardiogenic shock
 Initial evaluation & rapid stabilization
 Immediate ECG:
 Look for evidence of AMI (ST ele , LBBB)
 Supplemental O2/mech vent
 BP support
 Dopamine
 Nor epi
Need CVP,Intra arterial blood pressure monitoring
Cardiogenic shock
 Patient with positive ECG finding :
 Immediate reperfusion therapy :
 Thrombolytic therapy
 Cardiac catheterization
 Negative ECG finding :
 Rule out mechanical cause of CS ( ECHO)
 Cardiac monitoring ( confirm cardiac etiology )
 Continued medical support (vasopressure, inotropic)
Cardiogenic shock
 In case of refractory cardiac shock
 Left venticular assist device
 Transplant
 Cradiac temponade :
 Beck’s triad ( raised jvp,muffled hreart sound,hypotension)
 Presence of pulsus paradox( insp fall in SBP>10)
 Echo finding
 Consider Subxiphoid Pericardiocentesis
Thank you

More Related Content

PPT
SPINAL ANAESTHESIA
PPT
Malignant Hyperthermia
PPTX
Rapid sequence induction (RSI)
 
PDF
Assessment of blood loss
PPT
PPT
Magnesium and anaesthesia
PPTX
PPTX
anaesthetic management of Meningomyelocele and its Surgical excision
SPINAL ANAESTHESIA
Malignant Hyperthermia
Rapid sequence induction (RSI)
 
Assessment of blood loss
Magnesium and anaesthesia
anaesthetic management of Meningomyelocele and its Surgical excision

What's hot (20)

PPT
Anesthesia and diabetes
PPTX
Pre anesthetic evaluation
PPTX
Rapid Sequence Induction & Intubation
PPTX
Peripheral nerve blocks
PPTX
intraoperative hypertension
 
PPT
CPR with anesthesia perspective 2021
PPTX
Anaphylaxis and anesthesia
PPTX
thyroid diseases and anesthesia management
PPTX
Anaesthesia for non obstetric surgery in pregnancy
PPT
Assessment of airway
PPT
Perioperative management of hypertension
PPTX
PPTX
Succinyl choline apnea sharath
PPTX
Nitrous oxide and its current status
PPT
Perioperative fluid therapy
PPTX
Hypotensive anesthesia
PPTX
Dexmedetomidine
PPT
CPR in Pregnant Patients
PPT
Brachial plexus block
PPTX
Propofol ppt nandini
Anesthesia and diabetes
Pre anesthetic evaluation
Rapid Sequence Induction & Intubation
Peripheral nerve blocks
intraoperative hypertension
 
CPR with anesthesia perspective 2021
Anaphylaxis and anesthesia
thyroid diseases and anesthesia management
Anaesthesia for non obstetric surgery in pregnancy
Assessment of airway
Perioperative management of hypertension
Succinyl choline apnea sharath
Nitrous oxide and its current status
Perioperative fluid therapy
Hypotensive anesthesia
Dexmedetomidine
CPR in Pregnant Patients
Brachial plexus block
Propofol ppt nandini
Ad

Similar to 02 shock (20)

PPTX
SHOCK .pptx
PPTX
Shock.pptx
PPTX
SHOCK IN CHILDREN.pptx
PPTX
SHOCK IN DENTISTRY , DIAGNOSIS AND MANAGEMENT
PPTX
shock medicine, surgery , medicine clinical 11 2024.pptx
PPTX
SEMINAR SURGERY approach for shock and its mgt
PPTX
Approach to Shock in pediatrics age group.pptx
PPTX
sepsis.pptxMNGHGBDHSB KJHDGBSHVCJB KJDCGHBYUHFB SDJKFHDUJ
PPTX
Types of Shock
PPTX
SHOCk ppt new surgery class from baily updated
PPTX
shock ppt final.pptx
PPT
Shock definiton types pathophysiology.ppt
PPT
Physiology of shock
PPTX
Presentation ppt
PDF
Obstetric shock.PDF
PPTX
SHOCK in dentistry causes and its management
PPTX
Shock.pptx
PDF
Care of patient with shock and managmend.pdf
SHOCK .pptx
Shock.pptx
SHOCK IN CHILDREN.pptx
SHOCK IN DENTISTRY , DIAGNOSIS AND MANAGEMENT
shock medicine, surgery , medicine clinical 11 2024.pptx
SEMINAR SURGERY approach for shock and its mgt
Approach to Shock in pediatrics age group.pptx
sepsis.pptxMNGHGBDHSB KJHDGBSHVCJB KJDCGHBYUHFB SDJKFHDUJ
Types of Shock
SHOCk ppt new surgery class from baily updated
shock ppt final.pptx
Shock definiton types pathophysiology.ppt
Physiology of shock
Presentation ppt
Obstetric shock.PDF
SHOCK in dentistry causes and its management
Shock.pptx
Care of patient with shock and managmend.pdf
Ad

More from anaesthesiology-mgmcri (20)

PPTX
brachial plexus blocks
PPT
Airway management part I
PPTX
neuromuscular blocking agents
PPT
intravenous fluid
PPT
local anesthetics
PPTX
preanasthetic evaluation
PPT
conduct of regional anaesthesia
PDF
conduct of general anaesthesia
PDF
Conduct of GA
PPT
intravenous induction agents
PPT
premedication
PPT
anesthesia history
PPTX
introduction to anaesthesia
PPT
intraoperative monitoring
PPT
Airway management
PPTX
Blood component therapy
PPTX
Blood component therapy part I
PPT
Intravenous cannulation
PPTX
Postoperative complications
PPT
Brachial plexus block
brachial plexus blocks
Airway management part I
neuromuscular blocking agents
intravenous fluid
local anesthetics
preanasthetic evaluation
conduct of regional anaesthesia
conduct of general anaesthesia
Conduct of GA
intravenous induction agents
premedication
anesthesia history
introduction to anaesthesia
intraoperative monitoring
Airway management
Blood component therapy
Blood component therapy part I
Intravenous cannulation
Postoperative complications
Brachial plexus block

Recently uploaded (20)

DOCX
ch 9 botes for OB aka Pregnant women eww
PPTX
ANALGESIC AND ANTI-INFLAMMssssssATORY DRUGS.pptx
PPTX
guidance--unit 1 semester-5 bsc nursing.
PPTX
Nancy Caroline Emergency Paramedic Chapter 15
PDF
cerebral aneurysm.. neurosurgery , anaesthesia
PDF
Zuri Health Pan-African Digital Health Innovator.pdf
PPTX
Public Health. Disasater mgt group 1.pptx
PPTX
unit1-introduction of nursing education..
PDF
Back node with known primary managementt
PPTX
Newer Technologies in medical field.pptx
PPTX
Nancy Caroline Emergency Paramedic Chapter 7
PDF
Essentials of Hysteroscopy at World Laparoscopy Hospital
PPTX
Fever and skin rash - Approach.pptxBy Dr Gururaja R , Paediatrician. An usef...
PPTX
Hospital Services healthcare management in india
PDF
Introduction to Clinical Psychology, 4th Edition by John Hunsley Test Bank.pdf
PPTX
Nepal health service act.pptx by Sunil Sharma
PPTX
ACUTE CALCULAR CHOLECYSTITIS: A CASE STUDY
PPT
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
PPT
Pyramid Points Acid Base Power Point (10).ppt
PPTX
Nancy Caroline Emergency Paramedic Chapter 8
ch 9 botes for OB aka Pregnant women eww
ANALGESIC AND ANTI-INFLAMMssssssATORY DRUGS.pptx
guidance--unit 1 semester-5 bsc nursing.
Nancy Caroline Emergency Paramedic Chapter 15
cerebral aneurysm.. neurosurgery , anaesthesia
Zuri Health Pan-African Digital Health Innovator.pdf
Public Health. Disasater mgt group 1.pptx
unit1-introduction of nursing education..
Back node with known primary managementt
Newer Technologies in medical field.pptx
Nancy Caroline Emergency Paramedic Chapter 7
Essentials of Hysteroscopy at World Laparoscopy Hospital
Fever and skin rash - Approach.pptxBy Dr Gururaja R , Paediatrician. An usef...
Hospital Services healthcare management in india
Introduction to Clinical Psychology, 4th Edition by John Hunsley Test Bank.pdf
Nepal health service act.pptx by Sunil Sharma
ACUTE CALCULAR CHOLECYSTITIS: A CASE STUDY
12.08.2025 Dr. Amrita Ghosh_Stocks Standards_ Smart_Inventory Management_GCLP...
Pyramid Points Acid Base Power Point (10).ppt
Nancy Caroline Emergency Paramedic Chapter 8

02 shock

  • 1. Shock Dr.Indubala Maurya MD,DNB Assistant Professor Dept of Aanesthesia & Critical Care MGMCRI
  • 2. Introduction  Shock can be defined as a state of inadequate or inappropriate tissue perfusion resulting in abnormal cellular metabolism.  Shock is associated with anaerobic metabolism, oxygen debt and tissue acidosis.
  • 3.  Combination of hemodynamic parameters:  MAP< 60  SBP<90  Clinical feature  Abnormal lab value ( lactate > 4 mmol/L)
  • 4. Types of shock  Hypovolemic shock  Distributive Shock  Cardiogenic Shock
  • 5. Hypovolemic shock  Hypovolemic shock is related to decreased intravascular volume, secondary to loss of:  Blood (e.g. trauma)---- > Hemorrhagic shock  Plasma (e.g. burns)  Water and electrolytes (e.g. vomiting, diarrhoea).
  • 7. Hypovolemic shock Management :  Establish vascular access ; large bore cannula , Send sample for Hb  Start fluid resuscitation depending on clinical presentation -----with crystalloid/Blood product  Hb > 9gm% ----> continue Fluid therapy  Hb < 9gm% --- > PRBC, correct coagulation abnormality  Search for source of bleeding : compression of visible vascular injury, exposure and control of internal bleeding, embolisation ,banding
  • 8. Measure CVP and MAP  CVP < 8 --------> continue Fluid therapy  CVP > 8 and MAP < 60 -----> Administer Vasopressor ( NE,DA)  CVP > 8 and MAP > 60 ------> Resuscitation complete  Others  Airway control  Plt/FFP  Activated factor VII  Calcium/magnesium supplement  Rewarming  Antibiotics  look for other cause of shock
  • 9. Distributive shock e.g.  Septic shock  Anaphylactic shock
  • 10. Septic shock Surviving sepsis campaign 2012 Sepsis is defined as the presence of infection together with systemic manifestations of infection. Severe sepsis is defined as sepsis plus sepsis-induced organ dysfunction or tissue hypo perfusion. Sepsis-induced hypotension is defined as a systolic blood pressure (SBP) < 90 mm Hg or mean arterial pressure (MAP) < 70 mm Hg or a SBP decrease > 40 mm Hg or less than two standard deviations below normal for age in the absence of other causes of hypotension
  • 11. Septic shock  Clinical feature SBP< 90 MAP < 70 Feature of severe sepsis :  Fever Hypothermia ,tachy,Tachypnea,Altered mental status, Leukocytosis ,Leukopenia.  With one or more organ involvement ( lung ,liver ,kidney )
  • 12. Septic shock Management Goals during the first 6 hrs of resuscitation: a) Central venous pressure 8–12 mm Hg b) Mean arterial pressure (MAP) ≥ 65 mm Hg c) Urine output ≥ 0.5 mL/kg/hr d) Central venous (superior vena cava) or mixed venous oxygen saturation 70% or 65%, respectively
  • 13.  CVP < 8  continue fluid resuscitation  CVP > 8 MAP < 65  add vasopressure MAP > 65  ScvO2 < 70 %  Add dobutamine  Transfuse if Hb < 7  ScvO2 > 70 %  achieved all goals
  • 14. •Fluid Therapy of Severe Sepsis: • Crystalloids as the initial fluid of choice in the resuscitation •Vasopressors • Norepinephrine as the first choice vasopressor •Inotropic Therapy • Dobutamine infusion • myocardial dysfunction as suggested by elevated cardiac filling pressures and low cardiac output. • ongoing signs of hypoperfusion, despite achieving adequate intravascular volume and adequate MAP •Blood Product Administration • Red blood cell transfusion if Hb <7.0 g/dL • Platelets prophylactically when counts are <10,000/mm3 in the absence of apparent bleeding
  • 15. Diagnosis : • Cultures as clinically appropriate before antimicrobial therapy • imaging •Antimicrobial Therapy • Administration of effective broad spectrum intravenous antimicrobials within the first hour of recognition of septic shock. • Not more than 5 days, De-escalate antibiotic therapy. • Duration of therapy typically 7–10 days •Source Control • eg: abscess drainage •Mechanical Ventilation of Sepsis-Induced ARDS
  • 16. Anaphylactic shock  Anaphylaxis :  life threating clinical manifestation  IgE mediated hypersensitivity  Mast cell and basophil degranulation  Anphylactoid rxn:  Not IgE mediated
  • 17. Anaphylactic shock  Causes  Anaphylaxis :  Food( Nuts,egg etc)  Antibiotics,vaccines blood n blood products,latex  Anaphylactoid rxn  NSAID  Opiates  Gamma globulin  antisera
  • 18. Anaphylactic shock  Clinical manifestations :  Eyes: conjuctival erthyrema, periorbital odema  Skin: pruritus flushing urticaria angioedema  CVS: hypotension, Tachy (Brady if severe), cardiac arrest  Resp: Dyspnea,wheezing,pulmonary odema  GIT : Nausea/vomiting,Diarrohea, Abdo pain
  • 19. Anaphylactic shock  Suspected impending respiratory collapse ----> intubate  IM epinephrine 0.3-0.5 mg to ant/ lat thigh  For severe symptoms poor response  Iv bolus epinephrine 0.1-0.2 mg  If hypotensive start fliud therapy  if no response to above  start iv epi infusion  Aggressive fluid therapy  Pt on beta blocker ----> Glucagon
  • 20.  Treat all patients with Histamine 1,2 blocker Diphenhydramine (H1) Ranitidine (H2)
  • 21. Cardiogenic shock  Cardiogenic shock is related to ‘pump’ failure from many possible causes  myocardial infarct ( common)  valve dysfunction  papillae rupture  arrhythmias  tamponade  pulmonary embolus
  • 22. Cardiogenic shock  Clinical feature SBP< 90 Sign of low cardiac output ( oliguria,poor mental status , pulmonary odema )  Adequate intravascular volume ( PAOP > 15 mmhg)
  • 23. Cardiogenic shock  Initial evaluation & rapid stabilization  Immediate ECG:  Look for evidence of AMI (ST ele , LBBB)  Supplemental O2/mech vent  BP support  Dopamine  Nor epi Need CVP,Intra arterial blood pressure monitoring
  • 24. Cardiogenic shock  Patient with positive ECG finding :  Immediate reperfusion therapy :  Thrombolytic therapy  Cardiac catheterization  Negative ECG finding :  Rule out mechanical cause of CS ( ECHO)  Cardiac monitoring ( confirm cardiac etiology )  Continued medical support (vasopressure, inotropic)
  • 25. Cardiogenic shock  In case of refractory cardiac shock  Left venticular assist device  Transplant  Cradiac temponade :  Beck’s triad ( raised jvp,muffled hreart sound,hypotension)  Presence of pulsus paradox( insp fall in SBP>10)  Echo finding  Consider Subxiphoid Pericardiocentesis

Editor's Notes

  • #3: Shock can be defined as a state of inadequate cellular sustenance associated with inadequate or inappropriate tissue perfusion resulting in abnormal cellular metabolism. This can occur as a result of inadequate DO2, maldistribution of blood flow, a low perfusion pressure, or, as usually is the case, a combination of all three. Shock is associated with anaerobic metabolism, oxygen debt and tissue acidosis
  • #4: Clinical feature : poor MS, decresed urine out put, cold calmy skin, tachy ,
  • #5: There are many classifications of shock, some based on clinical entities and some on pathophysiology. This is somewhat unreal, as there is a large overlap between some of the groups, especially in their more severe forms and one or more processes may be involved simultaneously (Table 8.1). All forms of shock can eventually result in profound cellular dysfunction and death – so-called irreversible shock. Irreversibility is difficult to define and may depend on inappropriate management as much as on the clinical state. The following is a clinically useful initial approach to shock in association with the classical causes of shock (Table 8.1). The patient’s history is very important in determining the cause. Hypotension is often the first sign of shock. BP = cardiac output × systemic vascular resistance (SVR). Firstly, determine whether the problem is mainly one of decreased SVR or decreased cardiac output.
  • #11: Sepsis : Fever (&amp;gt; 38.3°C) Hypothermia (core temperature &amp;lt; 36°C) Heart rate &amp;gt; 90/min–1 or more than two sd above the normal value for age Tachypnea Altered mental status Leukocytosis (WBC count &amp;gt; 12,000 μL–1) Leukopenia severe sepsis : Organ dysfunction variables Arterial hypoxemia (Pao2/Fio2 &amp;lt; 300) Acute oliguria (urine output &amp;lt; 0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation) Creatinine increase &amp;gt; 0.5 mg/dL or 44.2 μmol/L Coagulation abnormalities (INR &amp;gt; 1.5 or aPTT &amp;gt; 60 s) Ileus (absent bowel sounds) Thrombocytopenia (platelet count &amp;lt; 100,000 μL–1) Hyperbilirubinemia (plasma total bilirubin &amp;gt; 4 mg/dL or 70 μmol/L)
  • #20: Tell about ephinephine prepartion
  • #22: Inadeqaute circulation and comprimised organ perfusion due to cardiac dysfunction